← Browse by Condition
Medical Condition
prostate adenocarcinoma
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 2, Phase 1, Phase 3
ClinicalMetric tracks all active clinical trials for prostate adenocarcinoma sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — prostate adenocarcinoma Clinical Trials
How many clinical trials are currently recruiting for prostate adenocarcinoma?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for prostate adenocarcinoma, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for prostate adenocarcinoma?
prostate adenocarcinoma research spans Phase 1 (2 trials), Phase 2 (5 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a prostate adenocarcinoma clinical trial?
Eligibility criteria for prostate adenocarcinoma trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 2 5
Phase 3 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05726292 Phase 2
Recruiting
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Enrollment
90 pts
Location
United States
Sponsor
University of Chicago
NCT06330805 Phase 2
Recruiting
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer
Enrollment
70 pts
Location
United States
Sponsor
Ohio State University Comprehe...
NCT06044857 Phase 1
Recruiting
PSMA PET Response Guided SabR in High Risk Pca
Enrollment
20 pts
Location
United States
Sponsor
University of Texas Southweste...
NCT04146077
Recruiting
Active Surveillance for Low Risk Prostate Cancer
Enrollment
100 pts
Location
Russia
Sponsor
I.M. Sechenov First Moscow Sta...
NCT05931419
Recruiting
High-Risk prostatE Cancer radiatiOn Versus surgERy
Enrollment
837 pts
Location
Netherlands
Sponsor
Comprehensive Cancer Centre Th...
NCT05109208
Recruiting
The Use of Ultrasound in Assessing Post-prostatectomy Erectile Dysfunction
Enrollment
10 pts
Location
United States
Sponsor
Mayo Clinic
NCT05946213 Phase 3
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Enrollment
1,209 pts
Location
United States, Canad...
Sponsor
NRG Oncology
NCT06369610 Phase 2
Recruiting
Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer
Enrollment
110 pts
Location
United States
Sponsor
Mayo Clinic
NCT03821246 Phase 2
Recruiting
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
Enrollment
68 pts
Location
United States
Sponsor
David Oh
NCT06798558 Phase 2
Recruiting
Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
Enrollment
54 pts
Location
United States
Sponsor
Hackensack Meridian Health
NCT05983432 Phase 1
Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Enrollment
470 pts
Location
United States, Franc...
Sponsor
SystImmune Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology